San Francisco facilities and business and other statements that are not historical facts. This press release contains forward-looking statements, including, but not limited to, statements related to Horizon’s plans to expand its R&D capabilities, the potential benefits of its South Incredible lengths to impact lives, please visit follow us on Twitter, like us on Facebook or explore career opportunities on LinkedIn. We believe science and compassion must work together to transform lives. Scientific expertise and courage to bring clinically meaningful therapies to patients. Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases.
“We welcome theirĪddition to the over 3,400 life sciences companies in California, and eagerly await their contributions to California and the industry.” “Horizon brings nearly a decade of rare disease expertise to the Bay Area,” said Mike Guerra, president and chief executive officer of the California Life Sciences Association.
Horizon plans to add new positions in bioanalysis, clinical research, pharmacology, manufacturing and business development during the next year. “We look forward to exploring new partnerships in the South San Francisco biotech hub, and tapping into the wealth of talent in the area’s biotech and academicĬommunities, as we develop new solutions to address needs in rare diseases and beyond.” “This new facility will allow us to function more seamlessly and efficiently as we expand our pipeline,” said Srini Ramanathan Ph.D., vice president, development sciences and site head for the
0 kommentar(er)
